3 British Undervalued Stocks With At Least 14% Earnings Growth

Bank of England officials are warning that the UK economy is stuck in low gear, with younger workers feeling the strain as hiring stalls. That kind of sluggish backdrop often pushes attention toward profitable, financially robust British businesses that trade below what their cash flows might justify. This article walks through three such high quality undervalued shares from our screener and explains why each could deserve a closer look now.

The three stocks highlighted below are only a starter pack, and the full High Quality Undervalued Stocks screen surfaced 13 more businesses with equally compelling stories that are not covered here. To go straight to the source, analyze potential opportunities, and identify your own highest conviction ideas, head into the High Quality Undervalued Stocks screener.

Atalaya Mining Copper (LSE:ATYM)

Overview: Atalaya Mining Copper is a Spain based miner whose Proyecto Riotinto open pit copper operation generates concentrated copper, silver and gold output.

Operations: Atalaya Mining Copper produces €492.9 million from mining, exploration and related sales, with €454.6 million earned in Spain and €38.2 million in Cyprus.

Market Cap: £1.35b

Atalaya Mining Copper matters in this High Quality Undervalued Stocks screen because Proyecto Riotinto is already generating meaningful cash. The analyst consensus Narrative on Simply Wall St sees further potential if the Spanish growth pipeline is delivered.

"Atalaya Mining Copper is still working toward key milestones on growth projects. The expected permitting and subsequent 18 month development of Proyecto Touro is projected to add 30,000 tonnes of copper per year at lower cash costs than current operations. This would lift future revenues and support higher net margins once the project is online."

What happens to those margins if a single cost and pricing pressure that rarely makes headlines moves in the opposite direction investors expect?

If that pressure flips, you will want the full narrative for Atalaya Mining Copper that maps how Riotinto cash flows, Touro timing and cost curves could decouple from consensus expectations.

AstraZeneca (LSE:AZN)

Overview: AstraZeneca is a global biopharmaceutical group that discovers, develops, manufactures and sells prescription medicines. Its strongest link to the High Quality Undervalued Stocks theme comes from its oncology and biopharma drugs.

Operations: AstraZeneca generates US$62.4b from pharmaceuticals, reflecting a broad prescription medicine portfolio across oncology, cardiovascular, respiratory, vaccines and rare diseases.

Market Cap: £218.2b

A key aspect of AstraZeneca’s alignment with this screener is the mix of established oncology blockbusters and a deep late stage research pipeline that the analyst consensus Narrative on Simply Wall St views as underappreciated by the current share price.

"The company's robust and diversified late-stage pipeline, particularly in oncology, rare diseases, and cardiovascular or metabolic therapies, is now underpinned by management's disclosure of 12 programs each with risk adjusted peak sales potential above US$5b and several more in the US$3b to US$5b range. This could support high margin revenue growth and earnings as these assets progress from development to launch."

A central question for AstraZeneca is how any future pressure on its cost base and capital spending may shape those potential margins.

That cost pressure is exactly where the story could pivot. Read the full narrative for AstraZeneca to see how AstraZeneca's pipeline and capital spend might still accelerate earnings power.

BAE Systems (LSE:BA.)

Overview: BAE Systems is a London headquartered defence contractor that supplies combat aircraft, warships, munitions, cyber services and high margin electronics to governments worldwide.

Operations: BAE Systems generates about £7.8b from Electronic Systems, £7.7b from Air and £5.3b from Platforms & Services, supported by sizeable US and UK defence customers.

Market Cap: £54.1b

BAE Systems taps directly into the High Quality Undervalued Stocks theme through its Electronic Systems and Platforms & Services divisions. Long duration government contracts for defence electronics, precision weapons, combat vehicles and ship support translate into recurring cash flows that back a solid balance sheet and a growing project pipeline. The analyst consensus Narrative on Simply Wall St views this as underpriced.

"The company's order backlog reached £84b with total backlog plus incumbent program positions of around £260b, which equals about 8x annual sales and points to multi year support for revenue and earnings."

What happens to that earnings power if one less visible pressure on how quickly new capacity turns backlog into profitable output moves in the wrong direction?

If that risk starts to bite, the full narrative for BAE Systems explains how BAE Systems’ backlog, margins and cash generation could still accelerate as programs move through the system.

Seeking Alternatives Before Momentum Flies

Fresh ideas tend to move first, and the best breakouts rarely wait around. Scan under the radar now, before the crowd catches on and the opportunity fades.

• Identify resilient income streams before yield chasers arrive by reviewing the 6 dividend fortresses, curated to highlight payouts that aim to hold up when momentum shifts.
• Monitor the next phase of the AI buildout and see which enablers provide the key infrastructure with the 53 AI infrastructure stocks while it still appears early.
• Explore the grid upgrade theme as electrification spending develops by using the 42 power grid technology and infrastructure stocks to see which operators are currently highlighted.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com